title: Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT).
abstract: OBJECTIVE
  The purpose of this study was to examine the epidemiology of transurethral resection of the prostate (TURP) and associated risks among Medicare beneficiaries during the period of 1984 to 1990.
  
  
  METHODS
  Medicare hospital claims for a 20% national sample of Medicare beneficiaries were used to identify TURPs performed during the study period. All reported rates were adjusted to the composition of the 1990 Medicare population. Risks of mortality and reoperation were evaluated using life-table methods.
  
  
  RESULTS
  The age-adjusted rate of TURP reached a peak in 1987 and declined thereafter. Similar trends were observed for all age groups. In 1990, the rates of TURP (including all indications) were approximately 25, 19, and 13 per 1000 for men over the age of 75, 70 to 74, and 65 to 69, respectively. The 30-day mortality following TURP for the treatment of benign prostatic hyperplasia (BPH) decreased from 1.20% in 1984 to 0.77% in 1990 (linear trend, p = 0.0001). The cumulative incidence of a second TURP among men with BPH has likewise decreased steadily over time; in this study, the average was 7.2% over 7 years (5.5% when the indication for the second TURP was restricted to BPH only).
  
  
  CONCLUSIONS
  The rate of TURP has been declining since 1987, conceivably due to increasing availability of alternative treatments or changes in treatment preferences of patients and physicians. Over the same period, the outcomes following TURPs have improved, perhaps due to improved surgical care and changes in patient selection.
authors.affiliation: Center for the Evaluative Clinical Sciences, Dartmouth Medical School, Hanover, New Hampshire.
authors.forename: G L
authors.initials: GL
authors.lastname: Lu-Yao
authors.forename: M J
authors.initials: MJ
authors.lastname: Barry
authors.forename: C H
authors.initials: CH
authors.lastname: Chang
authors.forename: J H
authors.initials: JH
authors.lastname: Wasson
authors.forename: J E
authors.initials: JE
authors.lastname: Wennberg
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D044383:Black People; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D016344:Medicare Part A; D011183:Postoperative Complications / Q000401:mortality / Q000601:surgery; D011468:Prostatectomy / Q000706:statistics & numerical data / Q000639:trends; D011470:Prostatic Hyperplasia / Q000208:ethnology / Q000401:mortality / Q000601:surgery*; D011471:Prostatic Neoplasms / Q000208:ethnology / Q000401:mortality / Q000601:surgery*; D012086:Reoperation; D012106:Research; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States; D044465:White People; D001741:Black or African American